Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
- NCT ID
| Study title | Condition | Phase | Location | NCT ID |
|---|---|---|---|---|
Rollover Study for Patients With Sickle Cell Disease Who Have Completed a Prior Novartis-Sponsored Crizanlizumab Study |
Sickle Cell Disease | Phase4 | Colombia Lebanon Oman United States View all |
NCT04657822 |
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V |
Lupus Nephritis | Phase2 | China France Germany India Malaysia Philippines Portugal Puerto Rico Singapore Spain Turkey (Türkiye) United States View all |
NCT05268289 |
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA) |
Spinal Muscular Atrophy (SMA) | Greece Ireland Israel Poland Portugal Romania Russia South Korea Taiwan United States View all |
NCT04174157 | |
Safety and Efficacy Study of Fingolimod in Taiwanese Adults (≥ 20years) With Relapsing Remitting Multiple Sclerosis |
Multiple Sclerosis | Phase4 | Taiwan | NCT04480853 |
Long-term Efficacy, Safety and Tolerability of Iptacopan in C3G or IC-MPGN |
C3 Glomerulopathy, Immune-complex-membranoproliferative Glomerulonephritis | Phase3 | Argentina Brazil China France Germany Greece Israel Italy Japan Netherlands Spain Switzerland Turkey (Türkiye) United Kingdom United States View all |
NCT03955445 |
A Study of 177Lu-FAP-2286 in Advanced Solid Tumors |
Solid Tumor | Phase1, Phase2 | Australia Canada France Italy Spain United States View all |
NCT04939610 |
Evaluate Long-term Safety, Tolerability and Efficacy of Iptacopan in Study Participants With aHUS |
Atypical Hemolytic Uremic Syndrome | Phase3 | Brazil China Czechia India View all |
NCT05795140 |
Study of Efficacy and Safety of Ruxolitinib in Chinese Participants With Corticosteroid-refractory Chronic Graft vs. Host Disease |
Graft vs. Host Disease, Chronic Graft vs. Host Disease, Corticosteroid-refractory Chronic Graft vs. Host Disease | Phase4 | China | NCT06824103 |
A Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib Versus Placebo in Adult Patients With Generalized Myasthenia Gravis |
Generalized Myasthenia Gravis | Phase3 | Argentina Australia Belgium Canada China France Georgia India Italy Japan Poland Romania South Korea Spain Taiwan United States View all |
NCT06744920 |
ELIOS - Investigational Biomarkers to Track Disease Modification in Active RRMS |
Relapsing Remitting Multiple Sclerosis (RRMS) | Phase4 | Canada | NCT06733922 |